← Eichor
Study identifier: NCT05020574 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Microbiome and Association With Implant Infections

Condition: Breast Cancer · Breast Cancer Female · Genetic Predisposition to Disease  ·  Sponsor: University of California, San Francisco

PhasePhase 2
Planned participants200
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The most common tissue expander-related infections are from Staphylococcus and Pseudomonas species. In addition, from breast tissue microbiome studies, Staphylococcus and Pseudomonas show variable abundance across samples. The investigator hypothesizes that participants undergoing mastectomy with high initial abundance of Staphylococcus and/or Pseudomonas are more likely to develop subsequent tissue expander-related infections from these respective organisms.

This description comes directly from the study's public registry record.

Talk to the study team

Laura Barnes, MD  ·  (415) 502-1259  ·  Laura.Barnes@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California, San FranciscoSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05020574